These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16214453

  • 1. Comparison of efficacy and safety assessment of fluvastatin in patients <65 years versus > or =65 years of age.
    Bruckert E, Verpilleux MP, Dejager S, Isaacsohn J.
    Am J Cardiol; 2005 Oct 15; 96(8):1142-8. PubMed ID: 16214453
    [Abstract] [Full Text] [Related]

  • 2. Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials.
    Winkler K, Ablethauser CB, Gimpelewicz C, Bortolini M, Isaacsohn JL.
    Clin Ther; 2007 Sep 15; 29(9):1987-2000. PubMed ID: 18035198
    [Abstract] [Full Text] [Related]

  • 3. The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.
    Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J.
    Int J Cardiol; 2007 Apr 12; 117(1):64-74. PubMed ID: 16889855
    [Abstract] [Full Text] [Related]

  • 4. Long-term event monitoring study of fluvastatin in Japanese patients with hypercholesterolemia: Efficacy and incidence of cardiac and other events in elderly patients (≥ 65 years old).
    Itakura H, Nakaya N, Kusunoki T, Shimizu N, Hirai S, Mochizuki S, Ishikawa T.
    J Cardiol; 2011 Jan 12; 57(1):77-88. PubMed ID: 21067897
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun 12; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 6. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
    Norby GE, Holme I, Fellström B, Jardine A, Cole E, Abedini S, Holdaas H, Assessment of Lescol in Renal Transplantation Study Group.
    Arthritis Rheum; 2009 Apr 12; 60(4):1060-4. PubMed ID: 19333947
    [Abstract] [Full Text] [Related]

  • 7. Safety profile of fluvastatin.
    Peters TK.
    Br J Clin Pract Suppl; 1994 Dec 12; (77):20-3. PubMed ID: 19489170
    [Abstract] [Full Text] [Related]

  • 8. Safety profile of fluvastatin.
    Peters TK.
    Br J Clin Pract Suppl; 1996 Jan 12; 77A():20-3. PubMed ID: 8729586
    [Abstract] [Full Text] [Related]

  • 9. Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention--a Lescol Intervention Prevention Study (LIPS) substudy.
    Arampatzis CA, Goedhart D, Serruys PW, Saia F, Lemos PA, de Feyter P, LIPS Investigators.
    Am Heart J; 2005 Feb 12; 149(2):329-35. PubMed ID: 15846273
    [Abstract] [Full Text] [Related]

  • 10. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 12; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 11. The renal safety profile of fluvastatin: results of a pooled analysis.
    Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J.
    Ren Fail; 2006 Sep 12; 28(6):487-92. PubMed ID: 16928618
    [Abstract] [Full Text] [Related]

  • 12. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan 12; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 13. Fluvastatin blunts the effect of a high-fat meal on plasma triglyceride and high-sensitivity C-reactive protein concentrations in patients at high risk for cardiovascular events.
    Liu L, Zhao SP, Hu M, Li JX.
    Coron Artery Dis; 2007 Sep 12; 18(6):489-93. PubMed ID: 17700222
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 12; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 15. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J.
    J Heart Lung Transplant; 2009 Jun 12; 28(6):598-604. PubMed ID: 19481021
    [Abstract] [Full Text] [Related]

  • 16. Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.
    Holdaas H, Fellström B, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Logan JO, Staffler B, Gimpelewicz C, ALERT Study Group.
    Nephrol Dial Transplant; 2005 May 12; 20(5):974-80. PubMed ID: 15784644
    [Abstract] [Full Text] [Related]

  • 17. Fluvastatin treatment is not associated with an increased incidence of cancer.
    Stein EA, Corsini A, Gimpelewicz CR, Bortolini M, Gil M.
    Int J Clin Pract; 2006 Sep 12; 60(9):1028-34. PubMed ID: 16939542
    [Abstract] [Full Text] [Related]

  • 18. Treatment of dyslipidaemias with fluvastatin.
    Peters TK.
    Br J Clin Pract Suppl; 1994 Dec 12; (77):16-9. PubMed ID: 19514133
    [Abstract] [Full Text] [Related]

  • 19. Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.
    Soveri I, Holdaas H, Jardine A, Gimpelewicz C, Staffler B, Fellström B.
    Nephrol Dial Transplant; 2006 Aug 12; 21(8):2282-9. PubMed ID: 16574686
    [Abstract] [Full Text] [Related]

  • 20. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1994 Dec 12; (77):28-32. PubMed ID: 19496270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.